Details, Fiction and who makes copyright semaglutide
In March 2025, the company announced new options for just a direct-to-purchaser providing of its Wegovy weight loss drug. The company recognized a brand new pharmacy, termed NovoCare, which would charge customers $499 each month for entry to the drug, less than 50 % the cost of the drug as a result of other pharmaceutical distribution networks.[53]